We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN DIEGO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from...
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2999 | 8.10540540541 | 3.7 | 4.02 | 3.44 | 996142 | 3.79624243 | CS |
4 | 0.6049 | 17.8173784978 | 3.395 | 4.02 | 2.98 | 933660 | 3.43111935 | CS |
12 | 1.7599 | 78.5669642857 | 2.24 | 4.02 | 2.18 | 1066257 | 3.14167893 | CS |
26 | 2.4899 | 164.894039735 | 1.51 | 4.02 | 1.48 | 718480 | 2.73655449 | CS |
52 | 2.2499 | 128.565714286 | 1.75 | 4.02 | 1.42 | 671131 | 2.64957406 | CS |
156 | 2.2499 | 128.565714286 | 1.75 | 4.02 | 1.42 | 671131 | 2.64957406 | CS |
260 | 2.2499 | 128.565714286 | 1.75 | 4.02 | 1.42 | 671131 | 2.64957406 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions